MMP-9 was first recognized as a prognostic factor related to LNM in intrahepatic cholangiocarcinoma (ICC) in 1999, with a higher expression indicating a higher risk of recurrence [36,37]. This evidence concerns the gene MMP9 and intrahepatic cholangiocarcinoma.